当前位置: 首页 >> 检索结果
共有 2446 条符合本次的查询结果, 用时 2.3458892 秒

341. Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: insights into situs ambiguus and heterotaxy.

作者: Adam J Shapiro.;Stephanie D Davis.;Thomas Ferkol.;Sharon D Dell.;Margaret Rosenfeld.;Kenneth N Olivier.;Scott D Sagel.;Carlos Milla.;Maimoona A Zariwala.;Whitney Wolf.;Johnny L Carson.;Milan J Hazucha.;Kimberlie Burns.;Blair Robinson.;Michael R Knowles.;Margaret W Leigh.; .
来源: Chest. 2014年146卷5期1176-1186页
Motile cilia dysfunction causes primary ciliary dyskinesia (PCD), situs inversus totalis (SI), and a spectrum of laterality defects, yet the prevalence of laterality defects other than SI in PCD has not been prospectively studied.

342. Efficacy and safety of early dexmedetomidine during noninvasive ventilation for patients with acute respiratory failure: a randomized, double-blind, placebo-controlled pilot study.

作者: John W Devlin.;Nada S Al-Qadheeb.;Amy Chi.;Russel J Roberts.;Imrana Qawi.;Erik Garpestad.;Nicholas S Hill.
来源: Chest. 2014年145卷6期1204-1212页
Successful application of noninvasive ventilation (NIV) for acute respiratory failure (ARF) requires patient cooperation and comfort. The efficacy and safety of early IV dexmedetomidine when added to protocolized, as-needed IV midazolam and fentanyl remain unclear.

343. Chinese water-pipe smoking and the risk of COPD.

作者: Jun She.;Ping Yang.;Yuqi Wang.;Xinyu Qin.;Jia Fan.;Yi Wang.;Guangsuo Gao.;Guangxiong Luo.;Kaixiang Ma.;Baoyan Li.;Caihua Li.;Xiangdong Wang.;Yuanlin Song.;Chunxue Bai.
来源: Chest. 2014年146卷4期924-931页
Studies show that the incidence of COPD has remained high in southwest China despite the 1976 National Stove Improvement Program for indoor air quality. Chinese water-pipe tobacco smoking (commonly referred to as water-pipe smoking), which is thought to be less harmful under the assumption that no charcoal is used and water filters tobacco smoke, is popular in China. We investigated whether Chinese water-pipe use and exposure are associated with the risk of COPD.

344. A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.

作者: Dinesh Shrikrishna.;Rebecca J Tanner.;Jen Y Lee.;Amanda Natanek.;Amy Lewis.;Patrick B Murphy.;Nicholas Hart.;John Moxham.;Hugh E Montgomery.;Paul R Kemp.;Michael I Polkey.;Nicholas S Hopkinson.
来源: Chest. 2014年146卷4期932-940页
Skeletal muscle impairment is a recognized complication of COPD, predicting mortality in severe disease. Increasing evidence implicates the renin-angiotensin system in control of muscle phenotype. We hypothesized that angiotensin-converting enzyme (ACE) inhibition would improve quadriceps function and exercise performance in COPD.

345. Attentional modulation of reflex cough.

作者: Thomas Janssens.;Mitchell Silva.;Paul W Davenport.;Ilse Van Diest.;Lieven J Dupont.;Omer Van den Bergh.
来源: Chest. 2014年146卷1期135-141页
Reflex cough is a defensive response generated in the brainstem in response to chemical and mechanical stimulation of the airways. However, converging evidence shows that reflex cough is also influenced by central neural control processes. In this study, we investigate whether reflex cough can be modulated by attentional focus on either external stimuli or internal cough-related stimuli.

346. Multidisciplinary Approach to Management of Maternal Asthma (MAMMA): a randomized controlled trial.

作者: Angelina S Lim.;Kay Stewart.;Michael J Abramson.;Susan P Walker.;Catherine L Smith.;Johnson George.
来源: Chest. 2014年145卷5期1046-1054页
Uncontrolled asthma during pregnancy is associated with maternal and perinatal hazards. A pharmacist-led intervention directed at improving maternal asthma control, involving multidisciplinary care, education, and regular monitoring to help reduce these risks, was developed and evaluated.

347. Cross-sectional survey on lobectomy approach (X-SOLA).

作者: Christopher Cao.;David H Tian.;Kevin Wolak.;Jonathan Oparka.;Jianxing He.;Joel Dunning.;William S Walker.;Tristan D Yan.
来源: Chest. 2014年146卷2期292-298页
Lobectomy for non-small cell lung cancer (NSCLC) can be performed either through open thoracotomy or video-assisted thoracoscopic surgery (VATS). To improve the understanding of current attitudes of the thoracic community toward VATS lobectomy, the Collaborative Research Group conducted the Cross-sectional Survey on Lobectomy Approach (X-SOLA) study. We surveyed a large cohort of lobectomy-performing thoracic surgeons to examine their adoption of VATS lobectomy and their opinions of this technique vs conventional open thoracotomy.

348. Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis.

作者: Dheeraj Gupta.;Devendra S Dadhwal.;Ritesh Agarwal.;Nalini Gupta.;Amanjit Bal.;Ashutosh N Aggarwal.
来源: Chest. 2014年146卷3期547-556页
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is superior to conventional transbronchial needle aspiration (cTBNA) in the staging of lung cancer. However, its efficiency in diagnosis of sarcoidosis when combined with endobronchial biopsy (EBB) and transbronchial lung biopsy (TBLB) has not been studied. This randomized controlled trial compares diagnostic yield of EBUS-TBNA vs cTBNA in combination with EBB and TBLB.

349. Use and outcomes of noninvasive positive pressure ventilation in acute care hospitals in Massachusetts.

作者: Aylin Ozsancak Ugurlu.;Samy S Sidhom.;Ali Khodabandeh.;Michael Ieong.;Chester Mohr.;Denis Y Lin.;Irwin Buchwald.;Imad Bahhady.;John Wengryn.;Vinay Maheshwari.;Nicholas S Hill.
来源: Chest. 2014年145卷5期964-971页
This study determined actual utilization rates and outcomes of noninvasive positive pressure ventilation (NIV) at selected hospitals that had participated in a prior survey on NIV use.

350. Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma.

作者: Jie Zhu.;Simon D Message.;Yusheng Qiu.;Patrick Mallia.;Tatiana Kebadze.;Marco Contoli.;Christine K Ward.;Elliot S Barnathan.;Mary Ann Mascelli.;Onn M Kon.;Alberto Papi.;Luminita A Stanciu.;Peter K Jeffery.;Sebastian L Johnston.
来源: Chest. 2014年145卷6期1219-1229页
The nature of bronchial mucosal inflammation and its physiologic and clinical significance in rhinovirus-induced asthma exacerbations is unclear. We investigated bronchial mucosal inflammatory response and its association with physiologic and clinical outcomes in an experimental model of rhinovirus-induced asthma exacerbations.

351. Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study.

作者: Bartolome Celli.;Glenn Crater.;Sally Kilbride.;Rashmi Mehta.;Maggie Tabberer.;Chris J Kalberg.;Alison Church.
来源: Chest. 2014年145卷5期981-991页
Combination long-acting bronchodilator therapy may be more effective than long-acting bronchodilator monotherapy in chronic obstructive pulmonary disease (COPD).

352. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: a double-blind, randomized, controlled trial.

作者: Abdullah A Alangari.;Nidal Malhis.;Mohamed Mubasher.;Najwa Al-Ghamedi.;Mohamad Al-Tannir.;Muhammad Riaz.;Dale T Umetsu.;Saleh Al-Tamimi.
来源: Chest. 2014年145卷4期772-778页
Inhaled corticosteroids, known to be effective as a maintenance medication in chronic asthma, have also been suggested as a therapy for acute asthma when given at high doses.

353. Young "healthy" smokers have functional and inflammatory changes in the nasal and the lower airways.

作者: Marina Lazzari Nicola.;Heráclito Barbosa de Carvalho.;Carolina Tieko Yoshida.;Fabyana Maria Dos Anjos.;Mayumi Nakao.;Ubiratan de Paula Santos.;Karina Helena Morais Cardozo.;Valdemir Melechco Carvalho.;Ernani Pinto.;Sandra Helena Poliselli Farsky.;Paulo Hilario Nascimento Saldiva.;Bruce K Rubin.;Naomi Kondo Nakagawa.
来源: Chest. 2014年145卷5期998-1005页
Smoking is responsible for most COPD. Although people with COPD often have concomitant nasal disease, there are few studies that report physiologic or inflammatory changes in the upper airways in young asymptomatic smokers. We investigated physiologic and inflammatory changes in the nasal and lower airways of young smokers and if these changes were related to smoking history.

354. Neurobehavioral functioning and survival following lung transplantation.

作者: Patrick J Smith.;James A Blumenthal.;Robert M Carney.;Kenneth E Freedland.;C Virginia F O'Hayer.;Elbert P Trulock.;Tereza Martinu.;Todd A Schwartz.;Benson M Hoffman.;Gary G Koch.;R Duane Davis.;Scott M Palmer.
来源: Chest. 2014年145卷3期604-611页
Neurobehavioral functioning is widely recognized as being an important consideration in lung transplant candidates, but little is known about whether these factors are related to clinical outcomes. The present study examined the relationship of neurobehavioral functioning, including measures of executive function and memory, depression, and anxiety, to long-term survival among lung transplant recipients.

355. Two-year follow-up in patients treated with emphysematous lung sealant for advanced emphysema.

作者: Mordechai R Kramer.;Yael Refaely.;Nimrod Maimon.;Dror Rosengarten.;Oren Fruchter.
来源: Chest. 2013年144卷5期1677-1680页
Endoscopic lung volume-reduction therapy for emphysema has been associated with therapeutic responses smaller in magnitude and less durable than surgical volume reduction (LVRS). Bronchoscopic emphysematous lung sealant (ELS) therapy has been shown to produce improvements in pulmonary function similar to surgery at 1 year. This case series summarizes safety and efficacy data of all patients from the initial ELS study out to 2 years. Between 1 and 2 years, there were three all-cause adverse events requiring hospitalization. One patient went on to successful lung transplant. Improvements relative to baseline in spirometry (change in FEV1: + 14.3 ± 33.1%; change in FVC: + 5.8 ± 23.2%) and diffusing capacity (change in diffusing capacity of the lung for carbon monoxide: + 10.6 ± 20.6%) were observed at 2 years. An exponential model fit to FEV₁ data at 6, 12, 18, and 24 months predicted improvements from a baseline of > 5% out to 4.1 years, similar to what has been reported following surgery. This report confirms long-term safety and efficacy following ELS therapy in advanced emphysema. Studies in a larger cohort are needed to define the role of ELS therapy in the treatment algorithm of patients with this condition.

356. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.

作者: Robert P Baughman.;Daniel A Culver.;Francis C Cordova.;Maria Padilla.;Kevin F Gibson.;Elyse E Lower.;Peter J Engel.
来源: Chest. 2014年145卷4期810-817页
Sarcoidosis-associated pulmonary hypertension (SAPH) is a common problem in patients with persistent dyspneic sarcoidosis. The objective of this study was to determine the effect of bosentan therapy on pulmonary arterial hemodynamics in patients with SAPH.

357. The emotional and cognitive impact of unexpected simulated patient death: a randomized controlled trial.

作者: Kristin Fraser.;James Huffman.;Irene Ma.;Matthew Sobczak.;Joanne McIlwrick.;Bruce Wright.;Kevin McLaughlin.
来源: Chest. 2014年145卷5期958-963页
Observational studies suggest that emotions experienced during simulation training may affect cognitive load and learning outcomes. The objective of this study was to manipulate emotions during simulation training and assess the impact on cognitive load and learning.

358. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.

作者: Ryushi Tazawa.;Yoshikazu Inoue.;Toru Arai.;Toshinori Takada.;Yasunori Kasahara.;Masayuki Hojo.;Shinya Ohkouchi.;Yoshiko Tsuchihashi.;Masanori Yokoba.;Ryosuke Eda.;Hideaki Nakayama.;Haruyuki Ishii.;Takahito Nei.;Konosuke Morimoto.;Yasuyuki Nasuhara.;Masahito Ebina.;Masanori Akira.;Toshio Ichiwata.;Koichiro Tatsumi.;Etsuro Yamaguchi.;Koh Nakata.
来源: Chest. 2014年145卷4期729-737页
Treatment of autoimmune pulmonary alveolar proteinosis (aPAP) by subcutaneous injection or inhaled therapy of granulocyte-macrophage colony-stimulating factor (GM-CSF) has been demonstrated to be safe and efficacious in several reports. However, some reports of subcutaneous injection described transient benefit in most instances. The durability of response to inhaled GM-CSF therapy is not well characterized.

359. Roflumilast for the treatment of COPD in an Asian population: a randomized, double-blind, parallel-group study.

作者: Jinping Zheng.;Jinghua Yang.;Xiangdong Zhou.;Li Zhao.;Fuxin Hui.;Haoyan Wang.;Chunxue Bai.;Ping Chen.;Huiping Li.;Jian Kang.;Manja Brose.;Frank Richard.;Udo-Michael Goehring.;Nanshan Zhong.
来源: Chest. 2014年145卷1期44-52页
Roflumilast is the only oral phosphodiesterase 4 inhibitor indicated for use in the treatment of COPD. Previous studies of roflumilast have predominantly involved European and North American populations. A large study was necessary to determine the efficacy and safety of roflumilast in a predominantly ethnic Chinese population.

360. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.

作者: John L Johnson.;Hendrik Geldenhuys.;Bonnie A Thiel.;Asma Toefy.;Sara Suliman.;Bernadette Pienaar.;Phalkun Chheng.;Thomas Scriba.;W Henry Boom.;Willem Hanekom.;Mark Hatherill.
来源: Chest. 2014年145卷3期612-7页
T-cell interferon-γ release assays (IGRAs) are used in the diagnosis of Mycobacterium tuberculosis infection and could be useful biomarkers of response to treatment of latent TB infection for clinical trials, infection control units, and TB programs.
共有 2446 条符合本次的查询结果, 用时 2.3458892 秒